The Cantargia team
Our management group is composed of people with extensive experience of research and pharmaceutical development from both large and small companies. We also have considerable experience in business development with previous experience of licensing pharmaceutical projects.
Close cooperation between management, founders and our in-house and external experts allows us to work effectively not only on development of our own projects, but also on scientific advances and business development. Work is done in close cooperation with an administrative board with extensive experience within our specialised area.
Management
Göran Forsberg, CEO
Bengt Jöndell, CFO
Liselotte Larsson, COO
Lars Thorsson, VP Clinical Development
David Liberg, VP Research
Nedjad Losic, VP Biometrics
Dominique Tersago, CMO
Research and development
Susanne Magnusson, Director Clinical Development
Camilla Rydberg Millrud, Project Manager Pre Clinical
Gabriel Svensson Birkedal, Senior Scientist Protein Chemistry, CMC
Sara Rattik, Project Manager Pre Clinical
Marie Wallén Öhman, Senior Director Clinical
Caitríona Grönberg, Project Manager Pre Clinical
Dorthe da Graça Thrige, Senior Project Director
Annika Sanfridson, Principal Scientist
Adnan Deronic, IP and Communications Manager
Helén Johansen Blanco, Senior Clinical Director
Johan Karlsson, Senior Scientist CMC
Petter Skoog, Pre Clinical Scientist
Marie Magnusson, Senior Clinical Supply Manager
Henrik Löfvall, Clinical Project Manager
Ida Markholm, Senior Data Manager / Bioinformatician
Administration and Finance
Nina Valkama, Executive Assistant
Johanna Christensen, Financial Controller
Founders
Thoas Fioretos, founder and scientific advisor
Marcus Järås, founder and scientific advisor
Kjell Sjöström, Innovagen, founder, biochemical development
